MGD019 DART
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MGD019 DART, covering 2025-03-06 to 2025-03-06. Get the full timeline:
Most recent: Clinical Trial Update: MGD019 DART® Protein in Unresectable/Metastatic Cancer [Phase 1]